business

Lilly’s One-Time Cholesterol Shot

Bloomberg Markets · May 26, 2026, 3:01 PM · Also reported by 2 other sources

Eli Lilly is developing a groundbreaking one-time gene-editing treatment that could permanently lower bad cholesterol and reduce heart disease risk. Bloomberg's Madison Muller joins Open Interest to break down the science, the risks, and why Lilly is racing to expand beyond obesity drugs into its ne

Read full story on Bloomberg Markets → More top stories

Also covered by

STAT News STAT+: Pharmalittle: We’re reading about a Lilly gene therapy for cholesterol, three new Lilly deals, and more STAT News STAT+: Eli Lilly says Verve’s gene editor lowers cholesterol levels in early study

Aggregated and edited by the Scoop newsroom. We surface news from Bloomberg Markets alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Lilly’s One-Time Cholesterol Shot

Also covered by

More in business